Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 5Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Adenocarcinoma of Lung 1

Interventions

Sorafenib 3cabozantinib 2Sodium 2Radiofrequency Ablation 2Metformin 2Data Collection 2vandetanib 1temsirolimus 1selpercatinib 1pembrolizumab 1lenvatinib 1apatinib 1acetaminophen, codeine drug combination 1Watchful Waiting 1Tramadol 1Thyroxine 1Thyroidectomy 1Thyroid (USP) 1Technetium Tc 99m Sestamibi 1Panobinostat 1Observation 1Negative-Pressure Wound Therapy 1NAc-Sar-Gly-Val-(d-allo-Ile)-Thr-Nva-Ile-Arg-ProNEt 1Lysine Acetyltransferase 5 1Iodine-131 1Interviews as Topic 1Indocyanine Green 1Hyperspectral Imaging 1Focus Groups 1Fluorescein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Thyroid Diseases × Technetium Tc 99m Sestamibi × Clear all
NCT03065218 2022-07-26

99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients

Medstar Health Research Institute

Phase 4 Terminated
4 enrolled 5 charts
Head & Neck

Thyroid Diseases, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡